The MFDS requirements for clinical trials in drug registration include obtaining ethical approval, ensuring compliance with Good Clinical Practice (GCP) standards, and submitting detailed trial protocols. Sponsors must provide comprehensive data on study design, participant recruitment, safety monitoring, and data analysis methods. Reporting of adverse events and transparent data sharing is also essential.